Robbins Arroyo LLP Is Investigating the Officers and Directors of Retrophin, Inc. (RTRX) on Behalf of Shareholders

Oct 29, 2018 08:44 pm
SAN DIEGO -- 

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Retrophin, Inc. (NASDAQ: RTRX) breached their fiduciary duties to shareholders. Retrophin is a biopharmaceutical company that focuses on the development and commercialization of therapies for the treatment of rare diseases.

View this press release on the firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/retrophin-inc-oct-2018/

Retrophin Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, [email protected], or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Sign up for our FREE portfolio monitoring service, Stock Watch.

Attorney Advertising. Past results do not guarantee a similar outcome.

Robbins Arroyo LLP
Leonid Kandinov
(619) 525-3990 or Toll Free (800) 350-6003
[email protected]
www.robbinsarroyo.com